Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4182.10 +0.3% SILVER 57.38 +0.4% COPPER 6.57 +0.2% OIL 98.41 +0.5% PALLADIUM 1119.00 −0.8% MON 0.385 −6.1% OMI 0.250 +0.0% BUFF 0.780 +0.0% FEO 0.670 +3.1% LIB 0.700 −2.8% NPR 0.640 +3.2% BVA 0.750 −1.3% ONAU 0.530 +1.9% FMR 0.225 +0.0% GSVR 0.352 +3.7% PHNM 0.345 +1.5% SLG 5.66 −1.0% CASA 0.065 +8.3% DRY 0.220 +2.3% SOMA 0.560 +0.0% GOLD 4182.10 +0.3% SILVER 57.38 +0.4% COPPER 6.57 +0.2% OIL 98.41 +0.5% PALLADIUM 1119.00 −0.8% MON 0.385 −6.1% OMI 0.250 +0.0% BUFF 0.780 +0.0% FEO 0.670 +3.1% LIB 0.700 −2.8% NPR 0.640 +3.2% BVA 0.750 −1.3% ONAU 0.530 +1.9% FMR 0.225 +0.0% GSVR 0.352 +3.7% PHNM 0.345 +1.5% SLG 5.66 −1.0% CASA 0.065 +8.3% DRY 0.220 +2.3% SOMA 0.560 +0.0%

Healthcare

Page 58
  1. Feb 19, 2026 · 17:27 · KNE

    Kane Biotech adds U.S. distributors for revyve products

    Kane Biotech adds U.S. distributors for revyve products

    01
  2. Feb 19, 2026 · 16:40 · WELL

    Well Health, Healwell roll out Welltrust

    Well Health, Healwell roll out Welltrust

    02
  3. Feb 19, 2026 · 12:46 · EPRX

    Eupraxia prices $55-million (U.S.) public offering

    Eupraxia prices $55-million (U.S.) public offering

    03
  4. Feb 19, 2026 · 09:00 · GSD

    Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine(TM), with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects

    Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine(TM), with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects

    04
  5. Feb 19, 2026 · 08:31 · CYTO

    Cytophage Announces Operational Restructuring

    Cytophage Announces Operational Restructuring

    05
  6. Feb 19, 2026 · 07:25 · KNE

    Kane Biotech Expands Commercial Activities in the United States

    Kane Biotech Expands Commercial Activities in the United States

    06
  7. Feb 19, 2026 · 07:00 · COV

    Covalon Announces Conference Call to Discuss First Quarter Fiscal 2026 Results

    Covalon Announces Conference Call to Discuss First Quarter Fiscal 2026 Results

    07
  8. Feb 19, 2026 · 07:00 · WELL

    WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

    WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

    08
  9. Feb 19, 2026 · 04:35 · 4543

    Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships

    Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships

    09
  10. Feb 19, 2026 · 03:59 · MBIO

    Mindbio arranges $650,000 private placement

    Mindbio arranges $650,000 private placement

    10
  11. Feb 18, 2026 · 19:03 · MRVL

    Marvel Biosciences obtains financing to develop drug

    Marvel Biosciences obtains financing to develop drug

    11
  12. Feb 18, 2026 · 19:01 · RVX

    Resverlogix Closes $2.8 Million Shares-for-Interest Private Placement

    Resverlogix Closes $2.8 Million Shares-for-Interest Private Placement

    12
  13. Feb 18, 2026 · 18:51 · MBIO

    Mindbio develops Edge AI for voice intoxication checks

    Mindbio develops Edge AI for voice intoxication checks

    13
  14. Feb 18, 2026 · 17:46 · GUD

    Knight seeks Brazilian regulatory okay for Niktimvo

    Knight seeks Brazilian regulatory okay for Niktimvo

    14
← Newer Older →